Fast tumor testing to guide treatment choices in younger people with glioblastoma
Original title: Biomarker-guided RAdiation-deferring Treatment in Younger GBM Patients - Pilot Study
How far along is this research?
This is a trial that is enrolling or has been updated. It is not a finding yet.
This is an early first test in a small number of people.
Status: Not yet recruiting. It has not opened yet. Ask your care team to watch for it if it looks like a fit.
The trial team last updated this record on . Always check the trial page for the latest.
The short version
This study tests whether quick tumor testing can help doctors pick the right treatment.
Who this trial is for. This study is for people under 55 years of age with glioblastoma: A glioma that is given grade 4. Grade 4 is the highest grade there is. The tumor grows fast. Treatment usually starts soon after it is found. It often means surgery, and then radiation and chemotherapy. See the glossary that has come back. Tumor tissue gets fast testing to look for markers that may point to certain treatments.
Where it stands. The trial has not reported results. It is checking whether fast tumor testing can be done across hospitals in Australia, and whether it is safe. It is also looking at whether the test gives doctors useful facts in time to help with treatment choices. The answers are not in yet.
What this means, and what it doesn't
What it could mean: Fast tumor testing could give a care team more facts about a tumor sooner. The study will also explore whether this approach can be an option other than radiotherapy, or lower how much is used. If this sounds like you, you could ask your care team about it. The trial team decides who can join.
What it doesn't mean: This does not mean the approach works. A trial is a test, not a proven treatment. Being in one is not a guarantee that it will help you. It is not a promise of a cure.
Source: ClinicalTrials.gov, October 30, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.